ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,998Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 300

$978K Total Retail Price of All Prescriptions

Rank: 10 out of 300

797 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 797 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 797 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 12,663 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 824 755 1 9
LISINOPRIL 530 446 2 4
SIMVASTATIN 445 375 3 5
AMLODIPINE BESYLATE 432 392 4 2
HYDROCHLOROTHIAZIDE 318 305 5 20
METFORMIN HCL 314 283 6 19
FUROSEMIDE 303 260 7 3
ATORVASTATIN CALCIUM 300 278 8 14
ATENOLOL 277 249 9 31
HYDROCODONE-ACETAMINOPHEN 256 181 S3 10 1
LOSARTAN POTASSIUM 236 232 11 29
PRAVASTATIN SODIUM 232 227 12 15
NEXIUM 223 187 13 17
METOPROLOL TARTRATE 221 202 14 13
PANTOPRAZOLE SODIUM 213 199 15 35
POTASSIUM CHLORIDE 211 184 16 22
CITALOPRAM HBR 209 164 17 54
OMEPRAZOLE 204 183 18 11
TRAMADOL HCL 170 167 19 23
GLIMEPIRIDE 155 145 20 51
RANITIDINE HCL 151 125 21 112
TAMSULOSIN HCL 144 136 22 8
GABAPENTIN 139 102 23 7
DOXYCYCLINE HYCLATE 136 116 24 83
AMLODIPINE BESYLATE-BENAZEPRIL 133 115 25 52
AZITHROMYCIN 127 92 26 72
DONEPEZIL HCL 122 122 27 57
CIPROFLOXACIN HCL 120 111 28 28
ALENDRONATE SODIUM 117 114 29 61
AMITRIPTYLINE HCL 114 101 R 30 66
GLYBURIDE-METFORMIN HCL 104 73 R 31 203
CLOPIDOGREL 104 86 31 18
FENOFIBRATE 101 72 33 98
ZOLPIDEM TARTRATE 98 80 34 21
DIOVAN 95 82 35 46
ALLOPURINOL 94 77 36 44
ESCITALOPRAM OXALATE 93 72 37 78
JANUVIA 91 74 38 100
METOPROLOL SUCCINATE 91 89 38 6
TRIAMTERENE-HCTZ 90 70 40 118
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 74 41 64
ALPRAZOLAM 89 71 41 88
WARFARIN SODIUM 88 74 43 10
SERTRALINE HCL 88 75 43 41
PLAVIX 85 77 45 24
MECLIZINE HCL 82 68 46 147
SYNTHROID 82 82 46 49
METHYLPREDNISOLONE 81 69 48 179
MIRTAZAPINE 81 57 48 152
FLUTICASONE PROPIONATE 80 60 50 34
VERAPAMIL ER 80 76 50 113
INSULIN SYRINGE 77 75 52 156
PAROXETINE HCL 72 66 53 216
GEMFIBROZIL 71 59 54 186
ISOSORBIDE MONONITRATE ER 70 66 55 32
BENAZEPRIL HCL 69 64 56 73
MELOXICAM 67 55 57 27
LOSARTAN-HYDROCHLOROTHIAZIDE 67 59 57 97
OXYBUTYNIN CHLORIDE ER 66 61 59 122
VENLAFAXINE HCL ER 65 47 60 213
FLUOXETINE HCL 64 56 61 117
DIOVAN HCT 64 49 61 94
LIPITOR 62 50 63 115
GLYBURIDE 62 59 R 63 283
ROPINIROLE HCL 62 47 63 121
CRESTOR 61 40 66 26
TIZANIDINE HCL 58 41 67 42
ZOSTAVAX 57 53 68 417
OXYCODONE HCL-ACETAMINOPHEN 54 22 S2 69 62
BUMETANIDE 54 50 69 126
CYMBALTA 51 36 71 37
AZELASTINE HCL 51 42 71 255
IRBESARTAN 50 41 73 344
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.